Do almonds lower cholesterol and blood sugar?

A 30g serving of almonds provides approximately 165 calories, 14g fat (9g monounsaturated, 3.5g polyunsaturated), 6g protein, 3.5g fibre, and meaningful amounts of:

• Vitamin E — roughly 7mg, covering about half the daily recommended intake. Almonds are among the richest whole-food sources of alpha-tocopherol, which protects cell membranes from oxidative damage and plays a role in immune function.
• Magnesium — about 75mg per serving (around 18% of the RDA). Magnesium participates in over 300 enzymatic reactions, including those governing blood sugar regulation, muscle contraction, and blood pressure.
• Calcium and phosphorus — supporting bone mineralisation.
• Polyphenols — concentrated mainly in the brown skin. Flavonoids, hydroxycinnamic acids, and flavonols act as antioxidants and modulate inflammatory signalling. Blanching or removing the skin substantially reduces polyphenol content, so whole skin-on almonds are nutritionally superior to blanched varieties.

The fat profile — predominantly oleic acid (the same monounsaturated fat found in olive oil) — contributes to almonds' cardiovascular effects and helps the body absorb fat-soluble nutrients.

Cardiovascular Health

Almonds have been studied against cardiovascular risk factors since the 1990s. The mechanistic picture is now fairly well understood: the monounsaturated fat in almonds replaces saturated fat in the diet, which lowers LDL and total cholesterol; the polyphenols and vitamin E reduce LDL oxidation (oxidised LDL is more atherogenic than unoxidised LDL); and plant sterols in almonds partially block cholesterol absorption in the intestine.

Jenkins et al. (2002) conducted a dose-response crossover trial showing that even partial replacement of dietary carbohydrate or saturated fat with almonds significantly reduced LDL and the LDL-to-HDL ratio, with effects scaling with the dose consumed.¹

Berryman et al. (2015) enrolled adults with elevated LDL in a crossover trial of two 6-week periods and found that a diet including 1.5 oz (about 43g) of almonds per day lowered LDL cholesterol by 5.3 mg/dL compared to a calorie-matched control.² Abdominal fat also decreased on the almond diet without any difference in total body weight, suggesting that swapping a high-carbohydrate snack for almonds may support a more favourable body composition without adding body fat.

Practical dose: Most cardiovascular trials used 30–60g per day. At 30g, the caloric addition is manageable; at this serving size, almonds consistently show lipid benefits without causing weight gain in controlled studies.

Blood Sugar and Insulin Sensitivity

Almonds may affect blood sugar in two ways: by slowing gastric emptying (through fat and fibre, which blunts the postprandial glucose spike after a meal), and through longer-term changes in insulin sensitivity with sustained consumption, which in the one long-term trial fell rather than improved.

Gulati et al. (2023) demonstrated that eating almonds before meals significantly flattened the glucose curve on an oral glucose tolerance test in people with prediabetes.⁴ Continuous glucose monitoring confirmed that almond consumers spent less time in elevated glucose ranges throughout the day compared to the control group. The blunting effect appeared to work partly by slowing gastric emptying and partly by providing substrates that support incretin hormone release.

Gravesteijn et al. (2023) examined longer-term effects in men and women with overweight or obesity and prediabetes who ate 50g of almonds a day for five months in a free-living crossover trial.³ Whole-body insulin sensitivity was significantly lower, and postprandial glucose and fasting insulin significantly higher, during the almond period than during the control period, while the 24-hour glucose area under the curve did not differ significantly. BMI, waist circumference and energy intake also rose, and the authors noted that almonds seemed not to have fully replaced other foods. The results are meaningful because insulin resistance is the primary driver of type 2 diabetes progression; the authors concluded that long-term almond consumption showed adverse effects on insulin sensitivity and glucose metabolism in prediabetes.

See our insulin resistance page for more on the mechanisms of glucose dysregulation.

Gut Microbiome

Almonds are unusual among nuts for their relatively high fibre content (including prebiotic insoluble fibre), which reaches the colon largely intact and feeds beneficial bacteria. The polyphenols in almond skins also escape absorption in the small intestine and undergo fermentation by colonic microbiota, producing bioactive metabolites.

Holscher et al. (2018) randomised 18 healthy adults in a crossover trial to diets containing whole almonds, chopped almonds, or almond flour for three weeks each.⁵ Whole almond consumption significantly increased Lachnospiraceae and Ruminococcaceae — fibre-fermenting families associated with butyrate production and gut barrier integrity — relative to the flour diet. The physical form of the almond mattered: whole and chopped almonds produced greater microbiome enrichment than almond flour, because intact cell walls resist digestion and deliver more substrate to the colon. The study also found that almond consumption increased Bifidobacteria counts compared to the almond-free baseline — a genus linked to immune regulation and reduced intestinal permeability.

For more on the relationship between fibre, fermentation, and gut health, see our butyrate page.

Satiety and Weight Management

One of the persistent concerns about eating calorie-dense nuts is weight gain. Short-term and controlled studies do not support this concern for almonds, although in one 5-month free-living trial in people with prediabetes, BMI, waist circumference and energy intake all rose³. Multiple mechanisms help explain why nut consumers do not gain disproportionate weight: the fat, fibre, and protein combination produces strong satiety signals that reduce intake at subsequent meals; a fraction of the fat in intact almond cells is not fully absorbed; and some evidence suggests modest thermogenic effects.

Hull et al. (2015) enrolled healthy women who consumed either a mid-morning snack of almonds or no snack. The almond group reported significantly greater satiety and consumed meaningfully fewer calories at the subsequent lunch meal, such that the net caloric impact of the almond snack was substantially attenuated.⁶ They also maintained more stable energy across the morning compared to the no-snack group, without the blood sugar fluctuation associated with refined carbohydrate snacks.

Practical use: Almonds work well as a pre-meal or between-meal snack when the goal is reducing overall food intake without relying on willpower alone — the satiety effect appears within 30–60 minutes of eating them.

How to Eat and Store

Whole, raw almonds with the skin intact maximise polyphenol and fibre delivery. Roasting at low temperatures (below 150°C) preserves most nutrients; commercial high-heat roasting may reduce some polyphenol content. Avoid heavily salted or sweetened varieties for health purposes.

Store almonds in an airtight container away from light and heat; at room temperature they keep well for several months. Refrigeration or freezing extends shelf life considerably. Like all nuts, almonds are susceptible to rancidity once their fats oxidise — taste is a reliable indicator of freshness.

Soaking almonds overnight reduces phytic acid content, which can bind minerals in the gut and reduce their absorption. Soaked almonds are softer and easier to digest — a practical option for people who experience digestive discomfort from raw nuts.

Dose-Response Cardiovascular Effects

Jenkins et al. (2002) conducted one of the first rigorous dose-response trials examining almonds and cardiovascular risk factors.¹ In a randomised crossover design, 27 hyperlipidaemic adults consumed three diets for four weeks each, replacing approximately 50% of the saturated fat in the control diet with either a full dose of almonds (73g/day), a half dose (37g/day), or a low-saturated-fat control (no almonds). The full almond diet reduced total cholesterol by 4.4% and LDL cholesterol by 7.0% compared to the control; the half dose produced intermediate reductions (2.3% and 4.4%, respectively). The full almond diet also significantly reduced oxidised LDL by 14%, an important finding because LDL oxidation status — not LDL concentration alone — predicts atherosclerotic risk. Lipoprotein(a) was unaffected. The dose-response relationship confirmed that even partial almond substitution within a typical diet produces measurable cardiovascular benefit, and that greater intakes confer greater benefit within a practical dietary range.

Cardiometabolic Risk in Adults with Elevated LDL

Berryman et al. (2015) enrolled 48 adults with elevated LDL-cholesterol in a randomised crossover controlled-feeding trial with two 6-week periods.² In one period participants ate a cholesterol-lowering diet containing 1.5 oz (about 43g) of almonds per day (as a snack replacement); in the other, an identical diet with an isocaloric muffin snack. Compared with the control diet, the almond diet lowered LDL cholesterol by 5.3 mg/dL and non-HDL cholesterol by 6.9 mg/dL. Abdominal fat was also significantly lower on the almond diet (0.07 kg less, alongside 0.12 kg less leg fat) even though total body weight did not differ, suggesting that the almond intervention shifted body composition favourably despite equivalent caloric intake. HDL cholesterol was maintained on the almond diet, whereas it fell by 1.7 mg/dL on the control diet. The authors concluded that daily almonds (1.5 oz), substituted for a high-carbohydrate snack, may be a simple dietary strategy to prevent the onset of cardiometabolic diseases in healthy individuals.

Insulin Sensitivity in Prediabetes: Long-Term RCT

Gravesteijn et al. (2023) studied 43 men and women with overweight or obesity and prediabetes in a randomised crossover trial: five months of daily almond consumption (50g/day) and five months of control, separated by a two-month washout, in a free-living setting without detailed dietary instructions.³ Whole-body insulin sensitivity was measured at the end of both periods by a hyperinsulinaemic-euglycaemic clamp — the gold standard method — alongside postprandial glucose responses and 48 hours of continuous glucose measurements. Insulin sensitivity was significantly lower after the almond period than after the control period (p = 0.002), and postprandial glucose concentrations (p = 0.019) and fasting insulin (p = 0.003) were higher. The 24-hour glucose area under the curve did not differ significantly (p = 0.066). BMI (p = 0.002) and waist circumference (p = 0.013) also rose, alongside energy intake (p = 0.031), and the effect on glucose metabolism remained after correcting for BMI changes. The authors concluded that long-term almond consumption showed adverse effects on insulin sensitivity and glucose metabolism in prediabetes, and noted that almonds seemed not to have fully replaced other foods, so more guidance may be needed on how to fit energy-dense nuts into the diet.

Premeal Almond Load and Glucose Profiles

Gulati et al. (2023) conducted two randomised crossover trials in Asian Indian adults with prediabetes.⁴ In the first, 60 participants underwent oral glucose tolerance tests with or without a 30g premeal almond dose. The almond group showed a 23.4% reduction in glucose area under the curve at 2 hours compared to the no-almond group (p < 0.001). In the second, 40 participants wore continuous glucose monitors during two dietary phases (with and without premeal almonds over 14 days); almond consumers spent significantly less time in elevated glucose ranges and had lower mean glucose levels throughout the monitoring period. Both trials were conducted in a South Asian population, which typically has higher insulin resistance at equivalent BMI compared to Western populations — making the findings particularly relevant for a group at elevated diabetes risk. The acute blunting of postprandial glucose appears to operate via delayed gastric emptying and enhanced GLP-1 secretion.

Gut Microbiome: Form Matters

Holscher et al. (2018) randomised 18 healthy adults (aged 18–65) to three dietary phases of three weeks each in a crossover design: whole almonds (42.5g/day), chopped almonds (42.5g/day), or almond flour (42.5g/day, equivalent in macronutrient composition).⁵ Gut microbiome composition was assessed by 16S rRNA sequencing of stool samples at the start and end of each phase. Whole almond consumption significantly increased the relative abundance of Lachnospiraceae and Ruminococcaceae compared to almond flour, and significantly increased Bifidobacterium abundance compared to baseline. Chopped almonds produced intermediate effects. The key insight is that physical processing of almonds dramatically alters their prebiotic potential: grinding almonds into flour removes the structural resistance that allows cellular contents, including fibre and polyphenols, to reach the colon. The study provides practical guidance: whole almonds (or at most coarsely chopped) deliver substantially more gut-microbiome benefit than almond flour or almond butter made from highly processed almonds.

Satiety Mechanisms

Hull et al. (2015) recruited 42 healthy women in a randomised crossover trial.⁶ Participants consumed either a 168-calorie mid-morning almond snack or no snack, then were served an ad libitum lunch two hours later. The almond snack produced significantly greater ratings of fullness and desire to eat less compared to no snack at the time of lunch. Critically, the almond group consumed approximately 150 fewer calories at lunch than the no-snack group — nearly offsetting the calories consumed in the almond snack. The net caloric impact of the almonds over the morning was substantially less than their face value, demonstrating the compensatory reduction in intake that explains why regular nut consumers do not gain weight despite the caloric density of nuts. The authors identified the combination of protein, fat, and fibre as the likely drivers of the sustained satiety signal, with none of the blood sugar rebound that follows a refined carbohydrate snack.

Strength of Evidence

The cardiovascular evidence for almonds is strong: multiple RCTs across different populations consistently show LDL reduction and improvements in the wider lipid profile, with the effects sustained across 4–6 week intervention periods. The effect size (approximately 4–7% LDL reduction) is modest but clinically meaningful when sustained over years.

The blood sugar and insulin sensitivity data are more recent but mixed: the 2023 premeal-almond trials point to flatter glucose responses, whereas the 2023 free-living trial using the insulin clamp method found lower insulin sensitivity after five months of daily almonds, a result that needs replication. The evidence supports almonds as a practical premeal tool for people managing blood sugar, not just cardiovascular risk, but not yet as a long-term insulin-sensitising food.

The gut microbiome findings from a single crossover trial are promising but require replication in larger studies with longer durations. The form-dependent effect (whole > chopped > flour) is a practically important finding that should inform how almonds are consumed if gut health is the goal.

The satiety data are consistent with the broader nut literature, although in the 5-month free-living trial in prediabetes BMI and energy intake rose. The mechanism is well understood.